Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

被引：0
|
作者：
Katerina Chatzidionysiou
Elisabeth Lie
Evgeny Nasonov
Galina Lukina
Merete Lund Hetland
Ulrik Tarp
Ioan Ancuta
Karel Pavelka
Dan C. Nordström
Cem Gabay
Helene Canhão
Matija Tomsic
Piet L. C. M. van Riel
Juan Gomez-Reino
Tore K. Kvien
Ronald F. van Vollenhoven
机构：
[1] Karolinska Universitetssjukhustet,Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00
[2] Diakonhjemmet Hospital,Department of Rheumatology
[3] ARBITER,DANBIO, Department of Rheumatology
[4] Institute of Rheumatology,Department of Rheumatology
[5] Copenhagen University Hospital at Glostrup,Rheumatic Diseases Portuguese Register
[6] Aarhus University Hospital,undefined
[7] Cantacuzino Hospital,undefined
[8] Charles University,undefined
[9] ROB-FIN Helsinki University Central Hospital,undefined
[10] SCQM registry,undefined
[11] University Hospital of Geneva,undefined
[12] Rheumatology Research Unit,undefined
[13] Instituto de Medicina Molecular,undefined
[14] University Medical Center,undefined
[15] Radboud University Nijmegen Medical Centre,undefined
[16] Hospital Clinico Universitet De Santiago,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Treatment Patterns in Rheumatoid Arthritis after Methotrexate: Data from the Ontario Best Practice Research Initiatives Cohort
    Pope, Janet
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Couto, Sandra
    Rampakakis, Emmanouil
    Sampalis, John
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1240 - 1240
  • [32] TREATMENT PATTERNS IN RHEUMATOID ARTHRITIS AFTER METHOTREXATE: DATA FROM THE ONTARIO BEST PRACTICE RESEARCH INITIATIVES COHORT
    Pope, J.
    Movahedi, M.
    Cesta, A.
    Li, X.
    Couto, S.
    Sampalis, J.
    Rampakakis, E.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 967 - 968
  • [33] VARIATIONS IN DISEASE ACTIVITY AND THERAPEUTIC MANAGEMENT OF RHEUMATOID ARTHRITIS IN DIFFERENT INTERNATIONAL REGIONS: A COMPARISON OF DATA FROM THE CORRONA INTERNATIONAL AND CORRONA US REGISTRIES
    Pappas, D. A.
    Lampl, K.
    Kremer, M.
    Radominski, S. C.
    Gal, J.
    Nyberg, F.
    Malaviya, A.
    Whitworth, A.
    Rillo, O.
    Gibofsky, A.
    Popkova, T.
    Ho, M.
    Laurindo, I.
    Reed, G. W.
    Kerzberg, E. M.
    Horne, L.
    Zahora, R.
    Saunders, K. C.
    Pons-Estel, B. A.
    Onofrei, A. U.
    Greenberg, J. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 400 - 400
  • [34] Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry
    Manders, Sofie H. M.
    Kievit, Wietske
    Jansen, Tim L. T. A.
    Stolk, Jan N.
    Visser, Henk
    Schilder, Annemarie M.
    Vonkeman, Harald E.
    Adang, Eddy
    van de Laar, Mart A. F. J.
    van Riel, Piet L. C. M.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (10) : 1787 - 1794
  • [35] A COST EFFECTIVENESS ANALYSIS OF INFLIXIMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN SWEDEN, BASED ON DATA FROM THE STURE REGISTRY
    Lekander, I
    Borgstrom, F.
    Carli, C.
    Svarvar, P.
    Ljung, T.
    van Vollenhoven, R.
    VALUE IN HEALTH, 2008, 11 (06) : A356 - A356
  • [36] Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study
    Flipo, R. -M.
    Constantin, A.
    Goupille, P.
    Chartier, M.
    Ohayon, A.
    Mariette, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (07) : 1377 - 1386
  • [37] DISCONTINUATION AND EFFECTIVENESS OF BARICITINIB IN RHEUMATOID ARTHRITIS ACCORDING TO PATIENT AGE AND PRIOR TREATMENT: 2-YEAR DATA FROM THE EUROPEAN COHORT OF THE RA-BEREAL STUDY
    Alten, R.
    Burmester, G. R.
    Edwards, C. J.
    Favalli, E. G.
    De La Torre, I.
    Ng, K.
    Haladyj, E.
    Gerwien, J.
    Zaremba-Pechmann, L.
    Fautrel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 724 - 725
  • [38] The Associations Between Genetic Factors and Rheumatoid Arthritis Treatment Patterns: Data from Two Large Healthcare Systems
    McDermott, Gregory
    Xiong, Xin
    Knevel, Rachel
    Cui, Jing
    Jeffway, Mary
    Panickan, Vidul
    Cagan, Andrew
    Sangar, Rahul
    Posner, Daniel
    Costa, Lauren
    Matty, Rachael
    Karlson, Elizabeth
    Ho, Yuk-Lam
    Cho, Kelly
    Duan, Rui
    Cai, Tianxi
    Liao, Katherine
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2746 - 2748
  • [39] Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen Cohort
    Mueller, Ruediger
    Mattow, Frederik
    Popp, Florian
    von Kempis, Johannes
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] COMPARABLE EFFICACY AND SAFETY OF TWO REGIMENS OF RHEUMATOID ARTHRITIS TREATMENT WITH TOFACITINIB: DATA FROM RUSSIAN NATIONAL REGISTRY
    Babaeva, A.
    Kalinina, E.
    Nasonov, E.
    Mazurov, V.
    Lukina, G.
    Davydova, A.
    Semizarova, I.
    Slyusar, O.
    Rasevich, T.
    Samigullina, R.
    Abdulganieva, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 635 - 635
12345